Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs

3 weeks ago 4

Shares of Swiss drugmaker Novartis climbed arsenic overmuch arsenic 4.8% successful aboriginal deals Tuesday aft it raised its full-year guidance pursuing better-than-expected first-quarter results.